GHK-CU (100mg Vial)

Summary: GHK-Cu Research Protocol (Educational / Non-Human)

Compound overview

• GHK-Cu (glycyl-L-histidyl-L-lysine–copper) is a naturally occurring copper-binding tripeptide studied for:
  • Collagen and elastin stimulation
  • Wound healing and tissue repair
  • Angiogenesis support
  • Antioxidant and anti-inflammatory effects 
• Human literature reports improved skin thickness, dermal density, and wrinkle reduction; research protocols extrapolate lower, conservative ranges for non-human models.

Reconstitution Reference (Educational)

“Reconstitution” is a fancy word that just means:

Mixing powder with water so it becomes liquid

In research settings:

• Scientists add special clean water (BACwater) to the vial
• The powder slowly melts into the water
• They wait a bit so it mixes evenly

• Vial content: 100 mg GHK-Cu (lyophilized)
• Diluent: 3.0 mL bacteriostatic water (BAC water)
• Resulting concentration:
  100 mg ÷ 3.0 mL = ~33.3 mg/mL

With a U-100 insulin syringe:

• 1.0 mL = 100 units
• 3.0 mL total volume = three full syringes to the 100-unit mark

Allow time for full dissolution after reconstitution (commonly ~20 minutes in reference protocols).

Research Dose Range (Preclinical Averages)

• Typical referenced range: 1–2 mg once daily
• Gradual titration over extended study periods (e.g., ~12 weeks) is commonly noted in educational summaries.
• Values are extrapolated from non-human/preclinical data, not clinical recommendations.

Dose Math: 2 mg Target Using U-100 Syringe

Concentration: 33.3 mg/mL

Volume needed for 2 mg:

• 2 mg ÷ 33.3 mg/mL ≈ 0.06 mL

U-100 syringe conversion:

• 1.0 mL = 100 units
• 0.06 mL = 6 units